ArticleContemporary oncology (Poznan, Poland)2022

Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score.

Heba F Taha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.